Advertisement
Home Tags Cancer: Laryngeal

Tag: Cancer: Laryngeal

Nonsteroidal anti-inflammatory drugs are correlated with better overall survival in patients with head and neck squamous cell carcinoma

ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients

Benefit not significant for aspirin use in patients with non-small cell lung cancer undergoing SBRT
Delaying time to treatment initiation beyond 60 days is associated with decreased overall survival and increased head and neck cancer recurrence

Delaying Treatment Worsens Head, Neck Cancer Outcomes

Findings show that survival declines, recurrence increases with delays of more than 60 days
Human papillomavirus (HPV) DNA detected from a mouth rinse may be an effective marker for prognosis during treatment of HPV-positive head and neck cancer

Mouth Rinse for HPV DNA May Be Biomarker in Head, Neck Cancer

Persistent detection of tumor-type HPV DNA during treatment tied to increased risk for recurrence, death
As distant metastasis in head and neck squamous cell carcinoma is a rare event

Chest CT May Be Better Than PET/CT for HNSCC Distant Metastasis Evaluation

Since distant metastasis only seen in 3 percent of head, neck cancers, chest CT more cost-effective
In patients with head and neck cancer

Mental Health Disorders Up After Head & Neck Cancer Diagnosis

Women, patients with history of tobacco use, alcohol use have significantly higher odds of MHDs
An increased incidence of glottic carcinoma related to human papillomavirus has been documented in recent years among young patients

Glottic Carcinoma Can Be HPV-Related Disease in Young Adults

Cases of glottic carcinoma in patients aged 30 years or younger tested positive for high-risk HPV
New symptom combinations that may indicate early symptoms of laryngeal cancer have been identified

Symptom Combos Suggesting Laryngeal Cancer Identified

10 features of laryngeal cancer with which patients presented in year before diagnosis identified
There may be a significant

9/11 Responders May Have Higher Head, Neck Cancer Risk

Authors call for ongoing monitoring, treatment of those initially exposed
Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer

Persistent Opioid Use High in Head, Neck Cancer Patients

Opioid use before treatment, tobacco use are risk factors for ongoing opioid use
For patients with recurrent or metastatic head and neck squamous cell carcinoma

Pembrolizumab Promising for Metastatic Head, Neck SCC

Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma